Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 1563.27 | 574 / 578 | 95% | 34.50 | 1092 / 1155 |
breast | 89% | 664.84 | 407 / 459 | 89% | 25.27 | 997 / 1118 |
intestine | 98% | 1143.31 | 948 / 966 | 77% | 16.39 | 408 / 527 |
bladder | 100% | 646.19 | 21 / 21 | 74% | 17.11 | 371 / 504 |
esophagus | 76% | 473.27 | 1100 / 1445 | 89% | 20.91 | 162 / 183 |
prostate | 82% | 404.16 | 202 / 245 | 78% | 14.69 | 394 / 502 |
thymus | 69% | 406.66 | 452 / 653 | 90% | 27.65 | 545 / 605 |
stomach | 64% | 347.37 | 230 / 359 | 81% | 20.69 | 233 / 286 |
ovary | 55% | 230.48 | 99 / 180 | 79% | 16.58 | 339 / 430 |
uterus | 55% | 215.62 | 94 / 170 | 76% | 15.96 | 347 / 459 |
kidney | 42% | 240.36 | 37 / 89 | 87% | 25.84 | 780 / 901 |
adrenal gland | 76% | 356.08 | 197 / 258 | 51% | 9.11 | 118 / 230 |
skin | 59% | 289.74 | 1073 / 1809 | 63% | 14.48 | 299 / 472 |
brain | 27% | 242.13 | 711 / 2642 | 74% | 16.53 | 521 / 705 |
pancreas | 9% | 31.45 | 30 / 328 | 91% | 33.68 | 162 / 178 |
spleen | 100% | 2321.25 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 1378.45 | 1181 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 947.12 | 1288 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2911.82 | 890 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 66.72 | 27 / 29 |
tonsil | 0% | 0 | 0 / 0 | 89% | 26.64 | 40 / 45 |
liver | 28% | 103.00 | 63 / 226 | 41% | 6.89 | 168 / 406 |
heart | 53% | 398.18 | 457 / 861 | 0% | 0 | 0 / 0 |
muscle | 11% | 33.63 | 91 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.34 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002407 | Biological process | dendritic cell chemotaxis |
GO_0006955 | Biological process | immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0002312 | Biological process | B cell activation involved in immune response |
GO_0010818 | Biological process | T cell chemotaxis |
GO_0036145 | Biological process | dendritic cell homeostasis |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0030595 | Biological process | leukocyte chemotaxis |
GO_0061470 | Biological process | T follicular helper cell differentiation |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0030316 | Biological process | osteoclast differentiation |
GO_0002313 | Biological process | mature B cell differentiation involved in immune response |
GO_0006959 | Biological process | humoral immune response |
GO_2000458 | Biological process | regulation of astrocyte chemotaxis |
GO_0005886 | Cellular component | plasma membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0008142 | Molecular function | oxysterol binding |
Gene name | GPR183 |
Protein name | G-protein coupled receptor 183 (Epstein-Barr virus-induced G-protein coupled receptor 2) (EBI2) (EBV-induced G-protein coupled receptor 2) (hEBI2) |
Synonyms | EBI2 |
Description | FUNCTION: G-protein coupled receptor expressed in lymphocytes that acts as a chemotactic receptor for B-cells, T-cells, splenic dendritic cells, monocytes/macrophages and astrocytes (By similarity). Receptor for oxysterol 7-alpha,25-dihydroxycholesterol (7-alpha,25-OHC) and other related oxysterols . Mediates cell positioning and movement of a number of cells by binding the 7-alpha,25-OHC ligand that forms a chemotactic gradient (By similarity). Binding of 7-alpha,25-OHC mediates the correct localization of B-cells during humoral immune responses (By similarity). Guides B-cell movement along the B-cell zone-T-cell zone boundary and later to interfollicular and outer follicular regions (By similarity). Its specific expression during B-cell maturation helps position B-cells appropriately for mounting T-dependent antibody responses (By similarity). Collaborates with CXCR5 to mediate B-cell migration; probably by forming a heterodimer with CXCR5 that affects the interaction between of CXCL13 and CXCR5 . Also acts as a chemotactic receptor for some T-cells upon binding to 7-alpha,25-OHC ligand (By similarity). Promotes follicular helper T (Tfh) cells differentiation by positioning activated T-cells at the follicle-T-zone interface, promoting contact of newly activated CD4 T-cells with activated dendritic cells and exposing them to Tfh-cell-promoting inducible costimulator (ICOS) ligand (By similarity). Expression in splenic dendritic cells is required for their homeostasis, localization and ability to induce B- and T-cell responses: GPR183 acts as a chemotactic receptor in dendritic cells that mediates the accumulation of CD4(+) dendritic cells in bridging channels (By similarity). Regulates migration of astrocytes and is involved in communication between astrocytes and macrophages . Promotes osteoclast precursor migration to bone surfaces (By similarity). Signals constitutively through G(i)-alpha, but not G(s)-alpha or G(q)-alpha . Signals constitutively also via MAPK1/3 (ERK1/2) (By similarity). . |
Accessions | ENST00000376414.5 P32249 |